These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37722134)

  • 1. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria.
    Chen L; Kang Z; Shen J; Zhao R; Miao Y; Zhang L; Zheng Z; Zhang Z; Liu N; Wang C; Fang H; Zhou J; Wang Y; Liu Z; Yang Y; Chen Q
    Sci Bull (Beijing); 2024 Jun; ():. PubMed ID: 38918142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
    Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
    Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jul; 183():278-291. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral
    Geng S; Guo P; Li X; Shi Y; Wang J; Cao M; Zhang Y; Zhang K; Li A; Song H; Zhang Z; Shi J; Liu J; Yang Y
    ACS Nano; 2024 Mar; 18(12):8971-8987. PubMed ID: 38497600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
    Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
    J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer.
    Hu J; Ran S; Huang Z; Liu Y; Hu H; Zhou Y; Ding X; Yin J; Zhang Y
    Acta Biomater; 2024 Jul; ():. PubMed ID: 38964527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.
    Parhi L; Alon-Maimon T; Sol A; Nejman D; Shhadeh A; Fainsod-Levi T; Yajuk O; Isaacson B; Abed J; Maalouf N; Nissan A; Sandbank J; Yehuda-Shnaidman E; Ponath F; Vogel J; Mandelboim O; Granot Z; Straussman R; Bachrach G
    Nat Commun; 2020 Jun; 11(1):3259. PubMed ID: 32591509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer.
    Xie S; Wei L; Liu Y; Meng J; Cao W; Qiu B; Li X
    J Control Release; 2024 Jan; 365():16-28. PubMed ID: 37956925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum carcinogenesis and drug delivery interventions.
    Chen Z; Huang L
    Adv Drug Deliv Rev; 2024 Jun; 209():115319. PubMed ID: 38643839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment.
    Zhang X; Wang Y; Fan R; Zhang L; Li Z; Zhang Y; Zheng W; Wang L; Liu B; Quan C
    Microbiol Spectr; 2023 Aug; 11(4):e0039423. PubMed ID: 37341631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
    Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
    Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
    Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.
    Gao Y; Bi D; Xie R; Li M; Guo J; Liu H; Guo X; Fang J; Ding T; Zhu H; Cao Y; Xing M; Zheng J; Xu Q; Xu Q; Wei Q; Qin H
    Signal Transduct Target Ther; 2021 Nov; 6(1):398. PubMed ID: 34795206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents.
    Su S; Bu Q; Bai X; Huang Y; Wang F; Hong J; Fang JY; Wu S; Sheng C
    Bioorg Chem; 2023 Sep; 138():106586. PubMed ID: 37178651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.